Skip to content
OpenCapital
Get started

Oaktree Specialty Lending OCSL Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66 logo
Phillips 66PSX
$5.15B+246%
3M logo
3MMMM
$3.73B-41.1%
eBay logo
eBayEBAY
$4.23B+1.9%
American Financial Group logo
American Financial GroupAFG
$1.35B+6.0%
Erie Indemnity Company logo
Erie Indemnity CompanyERIE
$268.62M+3.2%
W.R. Berkley logo
W.R. BerkleyWRB
$2.28B+32.6%

Other financials

Income statement

See full
Net income-$18.9M+47.9%
EPS (diluted)-$0.21+50.0%

Balance sheet

See full
Cash & equivalents$51.3M-52.6%
Total debt$1.5B+2.3%
Total equity$1.4B-6.3%
Total assets$2.9B-6.0%

Cash flow

See full
Operating cash flow$130.7M+111%

Valuation

See full
Market cap$1B-16.8%
Enterprise value$2.43B-4.4%
P/E20.2×-113×

Returns & leverage

See full
Return on equity3.5%+2.9pp
Debt / equity1.1×+0.1×

Where this comes from

Reported directly by Oaktree Specialty Lending in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Oaktree Specialty Lending’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oaktree Specialty Lending's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oaktree Specialty Lending's cash and cash equivalents, end of period?
Oaktree Specialty Lending (OCSL) reported cash and cash equivalents, end of period of $51.26M in Q1 2026.
How has Oaktree Specialty Lending's cash and cash equivalents, end of period changed year-over-year?
Oaktree Specialty Lending's cash and cash equivalents, end of period decreased by 52.6% year-over-year, from $108.21M to $51.26M.
What is the long-term trend for Oaktree Specialty Lending's cash and cash equivalents, end of period?
Over 4 years (2021 to 2025), Oaktree Specialty Lending's cash and cash equivalents, end of period has grown at a 26.0% compound annual growth rate (CAGR), from $31.64M to $79.63M.